Shuji Tohda Selected Research

Thymoma (Thymic Carcinoma)

1/2018	Effects of MERTK Inhibitors UNC569 and UNC1062 on the Growth of Acute Myeloid Leukaemia Cells.
8/2013	Effects of the HIF1 inhibitor, echinomycin, on growth and NOTCH signalling in leukaemia cells.
3/2013	Comparative effects of PP242 and rapamycin on mTOR signalling and NOTCH signalling in leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuji Tohda Research Topics

Disease

20	Leukemia 06/2020 - 05/2003
14	Neoplasms (Cancer) 01/2024 - 08/2006
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2020 - 05/2005
10	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 03/2024 - 11/2006
7	COVID-19 12/2023 - 01/2021
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2020 - 07/2007
6	Lymphoma (Lymphomas) 11/2017 - 09/2005
5	Infections 09/2022 - 03/2016
3	Sepsis (Septicemia) 12/2023 - 03/2012
3	Pneumonia (Pneumonitis) 01/2023 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
3	Myeloid Leukemia (Leukemia, Myelocytic) 09/2018 - 08/2004
3	Thymoma (Thymic Carcinoma) 01/2018 - 03/2013
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2017 - 11/2006
3	Chronic Hepatitis C 10/2017 - 11/2016
2	Thrombosis (Thrombus) 01/2023 - 01/2021
2	Hemorrhage 01/2021 - 04/2006
2	Hypoxia (Hypoxemia) 08/2019 - 08/2013
2	Hepatocellular Carcinoma (Hepatoma) 11/2016 - 06/2014
2	Thrombocytopenia (Thrombopenia) 01/2014 - 01/2008
2	Polycythemia Vera 01/2014 - 08/2012
2	Multiple Myeloma 04/2009 - 08/2006
1	Viremia 03/2024
1	Hemorrhagic Cystitis 03/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2024
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2023
1	Rheumatoid Arthritis 09/2023
1	Cholelithiasis 01/2022
1	Pneumoperitoneum 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Meningococcal Infections 01/2022
1	Hypertension (High Blood Pressure) 06/2021
1	Atherosclerosis 01/2021
1	Inflammation (Inflammations) 01/2021

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 07/2023 - 09/2005
9	LigandsIBA 09/2015 - 05/2003
5	Sirolimus (Rapamycin)FDA Link 08/2019 - 03/2013
5	Gamma Secretase Inhibitors and ModulatorsIBA 10/2010 - 11/2006
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2015
3	NF-kappa B (NF-kB)IBA 08/2019 - 09/2009
3	Ribavirin (Virazole)FDA LinkGeneric 10/2017 - 11/2016
3	Prednisolone (Predate)FDA LinkGeneric 04/2016 - 02/2002
3	Messenger RNA (mRNA)IBA 06/2014 - 07/2007
3	Notch1 ReceptorIBA 09/2012 - 11/2009
3	2- (2- (3,5- difluorophenyl)- acetylamino)- N- (1- methyl- 2- oxo- 5- phenyl- 2,3- dihydro- 1H- benzo(e)(1,4)diazepin- 3- yl)propionamideIBA 03/2011 - 02/2010
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2014
2	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2020
2	fibrin fragment D (D-dimer)IBA 06/2021 - 01/2021
2	HDL LipoproteinsIBA 01/2021 - 01/2018
2	c-Mer Tyrosine KinaseIBA 01/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2020 - 08/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 09/2005
2	Small Interfering RNA (siRNA)IBA 08/2018 - 10/2013
2	InterferonsIBA 01/2017 - 11/2016
2	16S Ribosomal RNAIBA 06/2014 - 03/2012
2	QuercetinIBA 03/2011 - 11/2009
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2011 - 10/2010
2	cyclopamineIBA 03/2011 - 11/2009
2	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2005 - 02/2002
1	Cyclin D3IBA 03/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2024
1	ThrombomodulinIBA 12/2023
1	Methotrexate (Mexate)FDA LinkGeneric 09/2023
1	Myc associated factor XIBA 07/2023
1	Basic Helix-Loop-Helix Transcription FactorsIBA 07/2023
1	Transcription Factors (Transcription Factor)IBA 07/2023
1	Notch ReceptorsIBA 07/2023
1	Cardiolipins (Cardiolipin)IBA 01/2023
1	AutoantigensIBA 01/2023
1	AntigensIBA 01/2023
1	Prothrombin (Factor II)IBA 01/2023
1	remdesivirIBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	PhosphatidylserinesIBA 01/2023
1	Antiphospholipid AntibodiesIBA 01/2023
1	A-factor (Streptomyces)IBA 09/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 09/2022
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2022
1	Interferon Type IIBA 01/2022
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	HomocysteineIBA 01/2022
1	Penicillins (Penicillin)FDA Link 01/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	polyacrylamideIBA 01/2021
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021

Therapy/Procedure

18	Therapeutics 03/2024 - 08/2006
3	Molecular Targeted Therapy 01/2017 - 03/2011
2	Hematopoietic Stem Cell Transplantation 03/2024 - 03/2012
2	Drug Therapy (Chemotherapy) 07/2007 - 02/2002
1	Laparoscopic Cholecystectomy 01/2022
1	Intravenous Anesthesia 01/2022
1	Orthopedic Procedures 01/2021